Advancing Protein Stabilization Therapeutic Development and DUBTAC Drug Discovery through Gene and Cell Engineering

Explore a 37-minute webinar presented by Dr. Yongli Shan, Associate Director of Discovery Biology at Vicinitas Therapeutics, focusing on advancing protein stabilization therapeutic development and DUBTAC drug discovery through gene and cell engineering. Delve into the crucial role of genetically modified cell models in accelerating the development of safe and effective therapeutics. Learn how manipulation of cell line genetics enables faithful replication of disease models for screening and evaluating potential drug candidates. Discover the importance of genetically engineered cell lines in induced-proximity-based small-molecule drug discovery, particularly for expressing protein targets or disease-related proteins within cells. Gain insights from Dr. Shan's expertise in protein homeostasis and drug discovery research. Earn PACE credits by watching the webinar and following the provided instructions. Connect with Labroots on various social media platforms for more scientific content and updates.

Advancing Protein Stabilization Therapeutic Development and DUBTAC Drug Discovery through Gene...